ChronoScale (CHRN) Shares Outstanding (Weighted Average) (2012 - 2026)

ChronoScale (CHRN) has 15 years of Shares Outstanding (Weighted Average) data on file, last reported at $3.6 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $3.6 million, up 110.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (up 110.45% YoY), and the FY2025 annual result was $2.4 million, up 80.51% from the prior year.
• Shares Outstanding (Weighted Average) climbed to $3.6 million in Q1 2026 per CHRN's latest filing, from $806000.0 in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $17.4 million in Q1 2024 and troughed at $1240.0 in Q2 2023.
• A 5-year average of $7.3 million and a median of $3.6 million in 2026 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) tumbled 99.99% in 2023, then surged 95706.45% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $13.0 million in 2022, then climbed by 6.98% to $13.9 million in 2023, then plunged by 90.31% to $1.3 million in 2024, then tumbled by 40.03% to $806000.0 in 2025, then soared by 342.06% to $3.6 million in 2026.
• Business Quant data shows CHRN's Shares Outstanding (Weighted Average) at $3.6 million in Q1 2026, $806000.0 in Q4 2025, and $2.6 million in Q3 2025.